Trial intelligence / Profile preview

Cassia fistula product for diaper area inflammation

IRCT20230314057713N1Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Apr 2023
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of cassia fistula in diaper dermatitis, sponsored by Babol University of Medical Sciences. Started Apr 2023; status: completed.

02

Drugs

cassia fistula
03

Conditions

diaper dermatitis

Beyond the preview

Go deeper on IRCT20230314057713N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230314057713N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call